Bio-Rad discloses Sartorius AG FY2024 results: revenue €3.38B, net profit €137.4M

BIO-RAD LABORATORIES, INC.

Sartorius AG reported FY2024 sales revenue of €3,380.7M, gross profit €1,524.4M, EBIT €392.6M.
Net profit for FY2024 was €137.4M; operating cash flow €976.2M, investing cash flow -€425.8M.
As of Dec 31, 2024, Sartorius had total assets €10,103.0M, total liabilities €6,205.2M, equity €3,897.8M.
Bio-Rad does not assume responsibility for Sartorius's publicly disclosed figures; refers to Sartorius's annual report.
Update relates to Bio-Rad's Investment in Sartorius AG section of its 2024 10-K filed Feb 14, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.